FI852221A7 - Sydän-verisuonilääkkeinä käytettäviä dihydropyridiinejä. - Google Patents

Sydän-verisuonilääkkeinä käytettäviä dihydropyridiinejä. Download PDF

Info

Publication number
FI852221A7
FI852221A7 FI852221A FI852221A FI852221A7 FI 852221 A7 FI852221 A7 FI 852221A7 FI 852221 A FI852221 A FI 852221A FI 852221 A FI852221 A FI 852221A FI 852221 A7 FI852221 A7 FI 852221A7
Authority
FI
Finland
Prior art keywords
cardiovascular drugs
dihydropyridines
dihydropyridines used
cardiovascular
drugs
Prior art date
Application number
FI852221A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI852221L (fi
FI852221A0 (fi
Inventor
Simon Fraser Campbell
Roger Peter Dickinson
John Edmund Arrowsmith
Peter Edward Cross
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI852221A0 publication Critical patent/FI852221A0/fi
Publication of FI852221L publication Critical patent/FI852221L/fi
Publication of FI852221A7 publication Critical patent/FI852221A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI852221A 1984-06-07 1985-06-03 Sydän-verisuonilääkkeinä käytettäviä dihydropyridiinejä. FI852221A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848414518A GB8414518D0 (en) 1984-06-07 1984-06-07 Therapeutic agents

Publications (3)

Publication Number Publication Date
FI852221A0 FI852221A0 (fi) 1985-06-03
FI852221L FI852221L (fi) 1985-12-08
FI852221A7 true FI852221A7 (fi) 1985-12-08

Family

ID=10562060

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852221A FI852221A7 (fi) 1984-06-07 1985-06-03 Sydän-verisuonilääkkeinä käytettäviä dihydropyridiinejä.

Country Status (14)

Country Link
US (1) US4647565A (enExample)
EP (1) EP0168151A1 (enExample)
JP (1) JPS6133185A (enExample)
KR (1) KR860000286A (enExample)
AU (1) AU554571B2 (enExample)
DK (1) DK253585A (enExample)
ES (1) ES8704480A1 (enExample)
FI (1) FI852221A7 (enExample)
GB (1) GB8414518D0 (enExample)
GR (1) GR851380B (enExample)
HU (1) HUT37933A (enExample)
IL (1) IL75427A0 (enExample)
PL (1) PL253820A1 (enExample)
PT (1) PT80596B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568677A (en) * 1983-07-23 1986-02-04 Pfizer Inc. 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents
GR851819B (enExample) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US6976162B1 (en) * 2000-06-28 2005-12-13 Intel Corporation Platform and method for establishing provable identities while maintaining privacy
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140695C (da) * 1976-05-07 1980-05-12 Synthelabo Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf
DK159079A (da) * 1978-05-18 1979-11-19 Pfizer Fremgangsmaade til fremstilling af derivater af 4-amino-2-piperidinoquinazolin eller syreadditionssalte deraf
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
EP0100189B1 (en) * 1982-07-22 1986-05-28 Pfizer Limited Dihydropyridine anti-ischaemic and antihypertensive agents

Also Published As

Publication number Publication date
KR860000286A (ko) 1986-01-27
PL253820A1 (en) 1986-07-01
EP0168151A1 (en) 1986-01-15
ES8704480A1 (es) 1987-04-01
IL75427A0 (en) 1985-10-31
JPS6133185A (ja) 1986-02-17
HUT37933A (en) 1986-03-28
AU554571B2 (en) 1986-08-28
GR851380B (enExample) 1985-11-25
DK253585D0 (da) 1985-06-06
AU4334785A (en) 1985-12-12
ES543997A0 (es) 1987-04-01
FI852221L (fi) 1985-12-08
PT80596B (en) 1987-04-21
GB8414518D0 (en) 1984-07-11
DK253585A (da) 1985-12-08
US4647565A (en) 1987-03-03
PT80596A (en) 1985-07-01
FI852221A0 (fi) 1985-06-03

Similar Documents

Publication Publication Date Title
DE3685409D1 (de) Antitumorzusammensetzung.
FI865037A0 (fi) Mikrobicida kompositioner.
FI864371L (fi) Tvaolkomposition.
FI873109A0 (fi) Buren polymerisationskatalysator.
FI863362A7 (fi) Farmaseuttinen koostumus.
FI885570L (fi) Foerfarande foer framstaellning av en buren metallocenalumoxankatalysator foer gasfaspolymerisering.
DE3668414D1 (de) Antidiarrhoee-zusammensetzungen.
FI862430L (fi) Polymerkomposition.
ES2019061B3 (es) Composicion quimiluminiscente.
DE3681140D1 (de) Polyaethylenzusammensetzung.
DE3684564D1 (de) Veterinaere zusammensetzungen.
FI863061L (fi) Tvaolkomposition.
DE3688458D1 (de) Polymerzusammensetzung.
DE3684626D1 (de) Schmerzstillende zusammensetzung.
DE3684003D1 (de) Propylen-polymer-zusammensetzung.
FI834692L (fi) Dihydropyridiner.
FI872733A0 (fi) Farmaceutiska kompositioner.
FI841597A7 (fi) Dihydropyridiner.
DE3686740D1 (de) Einkomponenthaertbare zusammensetzung.
FI872313A0 (fi) Farmaceutiska kompositioner.
FI860342A0 (fi) Polymeriserbara kompositioner.
IT1213453B (it) Composizione farmaceutica.
FI852222A7 (fi) Dihydropyridiinejä.
FI864516L (fi) Laogloeddrande kompositioner.
FI861271A0 (fi) Polymeriserbar komposition.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: PFIZER CORPORATION